Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripFri, 21 Aug 2026 21:25:28 +0000en1hourly1 https://insights.citeline.com/scrip/new-products/teva-and-viatris-lean-into-innovative-medicines-XDFSJYHPO5BLTHEPKJ36MEKB2M/<![CDATA[Teva And Viatris Lean Into Innovative Medicines ]]>premium

      
]]> https://feeds.feedblitz.com/~/968104244/0/scrip~Teva-And-Viatris-Lean-Into-Innovative-Medicines/https://insights.citeline.com/scrip/new-products/teva-and-viatris-lean-into-innovative-medicines-XDFSJYHPO5BLTHEPKJ36MEKB2M/
      
]]> Fri, 21 Aug 2026 21:20:05 +0000 https://insights.citeline.com/scrip/leadership/remembering-philip-brown-founder-of-scrip-3722BKWCUBCSFEXVIVCXCMI46M/<![CDATA[Remembering Philip Brown, Founder Of Scrip ]]>free

      
]]> https://feeds.feedblitz.com/~/968089118/0/scrip~Remembering-Philip-Brown-Founder-Of-Scrip/https://insights.citeline.com/scrip/leadership/remembering-philip-brown-founder-of-scrip-3722BKWCUBCSFEXVIVCXCMI46M/
      
]]> Fri, 21 Aug 2026 12:00:10 +0000 https://insights.citeline.com/scrip/business/earnings/bavarian-nordic-bucks-trend-with-travel-vaccines-boost-BLZBQDYLJRHA3CNIVUVGIRQUPQ/<![CDATA[Bavarian Nordic Bucks Trend With Travel Vaccines Boost]]>premium

      
]]> https://feeds.feedblitz.com/~/968089682/0/scrip~Bavarian-Nordic-Bucks-Trend-With-Travel-Vaccines-Boost/https://insights.citeline.com/scrip/business/earnings/bavarian-nordic-bucks-trend-with-travel-vaccines-boost-BLZBQDYLJRHA3CNIVUVGIRQUPQ/
      
]]> Fri, 21 Aug 2026 12:16:30 +0000 https://insights.citeline.com/scrip/business/deals/ambros-raising-150m-to-take-neridronate-to-market-alone-after-reverse-merger-GIWJIDLXXJCVZIMAOYPILE4O4A/<![CDATA[Ambros Raising $150m To Take Neridronate To Market Alone After Reverse Merger]]>premium

      
]]> https://feeds.feedblitz.com/~/968103929/0/scrip~Ambros-Raising-m-To-Take-Neridronate-To-Market-Alone-After-Reverse-Merger/https://insights.citeline.com/scrip/business/deals/ambros-raising-150m-to-take-neridronate-to-market-alone-after-reverse-merger-GIWJIDLXXJCVZIMAOYPILE4O4A/
      
]]> Fri, 21 Aug 2026 20:44:40 +0000 https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-biopharma-ipo-activity-booming-in-and-outside-of-the-us-7JVVM547XNDUXANDSM3C4WP77I/<![CDATA[Finance Watch: Biopharma IPO Activity Booming In And Outside Of The US]]>premium

      
]]> https://feeds.feedblitz.com/~/968103926/0/scrip~Finance-Watch-Biopharma-IPO-Activity-Booming-In-And-Outside-Of-The-US/https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-biopharma-ipo-activity-booming-in-and-outside-of-the-us-7JVVM547XNDUXANDSM3C4WP77I/
      
]]> Fri, 21 Aug 2026 20:56:00 +0000 https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-ex-gsk-exec-joins-olix-as-it-expands-its-rnai-platform-XJRDNA34VZEZ3CUR7M74Q532HI/<![CDATA[Executives On The Move: Ex-GSK Exec Joins OliX As It Expands Its RNAi Platform]]>premium

      
]]> https://feeds.feedblitz.com/~/968091020/0/scrip~Executives-On-The-Move-ExGSK-Exec-Joins-OliX-As-It-Expands-Its-RNAi-Platform/https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-ex-gsk-exec-joins-olix-as-it-expands-its-rnai-platform-XJRDNA34VZEZ3CUR7M74Q532HI/
      
]]> Fri, 21 Aug 2026 13:24:24 +0000 https://insights.citeline.com/scrip/therapeutic-category/anticancer/china-presents-stella-opportunities-for-bnct-AVKJFVFSFBCR5PRCVSKONSKKDU/<![CDATA[China Presents Stella Opportunities For BNCT ]]>premium

      
]]> https://feeds.feedblitz.com/~/968079488/0/scrip~China-Presents-Stella-Opportunities-For-BNCT/https://insights.citeline.com/scrip/therapeutic-category/anticancer/china-presents-stella-opportunities-for-bnct-AVKJFVFSFBCR5PRCVSKONSKKDU/
      
]]> Fri, 21 Aug 2026 07:08:31 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/cspc-advances-chemo-free-adc-combo-in-1l-nsclc-F5DKGN3YEJACBLZCBIV4LZBSWA/<![CDATA[CSPC Advances Chemo-Free ADC Combo In 1L NSCLC]]>premium

      
]]> https://feeds.feedblitz.com/~/968080376/0/scrip~CSPC-Advances-ChemoFree-ADC-Combo-In-L-NSCLC/https://insights.citeline.com/scrip/r-and-d/clinical-trials/cspc-advances-chemo-free-adc-combo-in-1l-nsclc-F5DKGN3YEJACBLZCBIV4LZBSWA/
      
]]> Fri, 21 Aug 2026 07:34:24 +0000 https://insights.citeline.com/scrip/new-products/ultragenyx-lands-genglycos-approval-and-sets-its-sights-on-a-prv-double-IOTVBBVXYNFA5ELBH4AUPWYRDU/<![CDATA[Ultragenyx Lands Genglycos Approval And Sets Its Sights On A PRV Double]]>premium

      
]]> https://feeds.feedblitz.com/~/968056193/0/scrip~Ultragenyx-Lands-Genglycos-Approval-And-Sets-Its-Sights-On-A-PRV-Double/https://insights.citeline.com/scrip/new-products/ultragenyx-lands-genglycos-approval-and-sets-its-sights-on-a-prv-double-IOTVBBVXYNFA5ELBH4AUPWYRDU/
      
]]> Thu, 20 Aug 2026 13:50:08 +0000 https://insights.citeline.com/scrip/therapeutic-category/alimentary-metabolic/gubra-ai-discovery-engine-uncovers-another-promising-obesity-therapy-2ORC3LKRWBCINK74OM7FUFFKOM/<![CDATA[Gubra AI Discovery Engine Uncovers Another Promising Obesity Therapy ]]>premium

      
]]> https://feeds.feedblitz.com/~/968059757/0/scrip~Gubra-AI-Discovery-Engine-Uncovers-Another-Promising-Obesity-Therapy/https://insights.citeline.com/scrip/therapeutic-category/alimentary-metabolic/gubra-ai-discovery-engine-uncovers-another-promising-obesity-therapy-2ORC3LKRWBCINK74OM7FUFFKOM/
      
]]> Thu, 20 Aug 2026 15:17:31 +0000 https://insights.citeline.com/scrip/digital-technologies/ai/agentic-ai-lowers-trial-costs-by-automating-clinical-research-tasks-4KGN6AJWSBGULDNEFKRTVUPORQ/<![CDATA[Agentic AI Lowers Trial Costs By Automating Clinical Research Tasks]]>premium

      
]]> https://feeds.feedblitz.com/~/968066072/0/scrip~Agentic-AI-Lowers-Trial-Costs-By-Automating-Clinical-Research-Tasks/https://insights.citeline.com/scrip/digital-technologies/ai/agentic-ai-lowers-trial-costs-by-automating-clinical-research-tasks-4KGN6AJWSBGULDNEFKRTVUPORQ/
      
]]> Thu, 20 Aug 2026 20:01:45 +0000 https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-venture-capital-investors-meet-biotechs-in-the-middle-KGARKEMANVAPDM65JNWMEG6KQY/<![CDATA[Finance Watch: Venture Capital Investors Meet Biotechs In The Middle]]>premium

      
]]> https://feeds.feedblitz.com/~/968066069/0/scrip~Finance-Watch-Venture-Capital-Investors-Meet-Biotechs-In-The-Middle/https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-venture-capital-investors-meet-biotechs-in-the-middle-KGARKEMANVAPDM65JNWMEG6KQY/
      
]]> Thu, 20 Aug 2026 20:03:14 +0000 https://insights.citeline.com/scrip/business/deals/lilly-goes-deeper-into-infectious-disease-with-amplitude-MAXD6RQKZJEI7AJDF3UKC2IOPE/<![CDATA[Lilly Goes Deeper Into Infectious Disease With Amplitude]]>premium

      
]]> https://feeds.feedblitz.com/~/968067026/0/scrip~Lilly-Goes-Deeper-Into-Infectious-Disease-With-Amplitude/https://insights.citeline.com/scrip/business/deals/lilly-goes-deeper-into-infectious-disease-with-amplitude-MAXD6RQKZJEI7AJDF3UKC2IOPE/
      
]]> Thu, 20 Aug 2026 20:33:58 +0000 https://insights.citeline.com/scrip/business/strategy/genmab-speeds-toward-new-product-launches-in-2027-LMFOA3I4DVG4VFUY6AAHDKDKI4/<![CDATA[Genmab Speeds Toward New Product Launches In 2027]]>premium

      
]]> https://feeds.feedblitz.com/~/968038427/0/scrip~Genmab-Speeds-Toward-New-Product-Launches-In/https://insights.citeline.com/scrip/business/strategy/genmab-speeds-toward-new-product-launches-in-2027-LMFOA3I4DVG4VFUY6AAHDKDKI4/
      
]]> Wed, 19 Aug 2026 23:37:27 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/moderna-and-mercks-mrna-cancer-combo-shines-in-phase-iii-melanoma-trial-FYQVAMGBZ5DBHGGLZG4B6RBCSA/<![CDATA[Moderna And Merck’s mRNA Cancer Combo Shines In Phase III Melanoma Trial]]>premium

      
]]> https://feeds.feedblitz.com/~/968024174/0/scrip~Moderna-And-Merck%e2%80%99s-mRNA-Cancer-Combo-Shines-In-Phase-III-Melanoma-Trial/https://insights.citeline.com/scrip/r-and-d/clinical-trials/moderna-and-mercks-mrna-cancer-combo-shines-in-phase-iii-melanoma-trial-FYQVAMGBZ5DBHGGLZG4B6RBCSA/
      
]]> Wed, 19 Aug 2026 13:48:40 +0000 https://insights.citeline.com/scrip/leadership/interviews/lundbeck-lays-foundation-to-scale-up-from-2027-FGUAD4G5ZRDIBCTIHYHITV7YBQ/<![CDATA[Lundbeck Lays Foundation To Scale Up From 2027]]>premium

      
]]> https://feeds.feedblitz.com/~/968024756/0/scrip~Lundbeck-Lays-Foundation-To-Scale-Up-From/https://insights.citeline.com/scrip/leadership/interviews/lundbeck-lays-foundation-to-scale-up-from-2027-FGUAD4G5ZRDIBCTIHYHITV7YBQ/
      
]]> Wed, 19 Aug 2026 14:06:21 +0000Søren Svendsen https://insights.citeline.com/scrip/rare-diseases/pasatrus-fda-approval-puts-regenerons-rare-disease-playbook-to-the-test-MCWAQDX5BBGGVJ7R3QD6QPKM24/<![CDATA[Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test]]>premium

      
]]> https://feeds.feedblitz.com/~/968036972/0/scrip~Pasatru%e2%80%99s-FDA-Approval-Puts-Regeneron%e2%80%99s-RareDisease-Playbook-To-The-Test/https://insights.citeline.com/scrip/rare-diseases/pasatrus-fda-approval-puts-regenerons-rare-disease-playbook-to-the-test-MCWAQDX5BBGGVJ7R3QD6QPKM24/
      
]]> Wed, 19 Aug 2026 21:53:09 +0000 https://insights.citeline.com/scrip/leadership/interviews/hutchmed-advances-global-early-trials-for-first-in-class-conjugates-EF3XJGYGTRAZHPFC3GJE7622HE/<![CDATA[HUTCHMED Advances Global Early Trials For First-In-Class Conjugates]]>premium

      
]]> https://feeds.feedblitz.com/~/968003702/0/scrip~HUTCHMED-Advances-Global-Early-Trials-For-FirstInClass-Conjugates/https://insights.citeline.com/scrip/leadership/interviews/hutchmed-advances-global-early-trials-for-first-in-class-conjugates-EF3XJGYGTRAZHPFC3GJE7622HE/
      
]]> Wed, 19 Aug 2026 05:57:02 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/regenerons-uveitis-setback-adds-to-string-of-recent-pipeline-challenges-KKWAB764VFHODL7VWI2YKQQU5A/<![CDATA[Regeneron’s Uveitis Setback Adds To String Of Recent Pipeline Challenges]]>premium

      
]]> https://feeds.feedblitz.com/~/968007758/0/scrip~Regeneron%e2%80%99s-Uveitis-Setback-Adds-To-String-Of-Recent-Pipeline-Challenges/https://insights.citeline.com/scrip/r-and-d/clinical-trials/regenerons-uveitis-setback-adds-to-string-of-recent-pipeline-challenges-KKWAB764VFHODL7VWI2YKQQU5A/
      
]]> Wed, 19 Aug 2026 09:24:22 +0000